What we do Gujarat Terce Laboratories Ltd manufactures high-quality, affordable oral solid dosage medicines including tablets and capsules for diverse therapeutic needs. |
Founded in 1,985 |
Market share Well-established in India with over 125 products and 64 brands, serving many Indian states with growing presence. |
Problem solved Provides accessible and effective pharmaceutical solutions for common health conditions through a broad portfolio and stringent quality standards. |
Top clients or who we serve Serves healthcare professionals, pharmacies, hospitals, and diverse patient demographics across India (B2B and B2C). |
Key management Aalap Natubhai Prajapati (Managing Director & CEO) leads a team of experienced pharma professionals. |
Our journey and innovations Founded in 1985, listed on BSE in 1992, expanded manufacturing, product range, and markets domestically and internationally over decades. |
Where we operate Operations across 13 Indian states and over 224 districts, with strong footholds in Northern, Western, and Central India. |
Top products or what we offer Over 130 pharmaceutical products including tablets, capsules, syrups, and injections across acute and chronic categories. |
Top brands Eight leading brands in key areas like Paediatrics, Gynaecology, Orthopaedics, and General Medicine, driving growth and market presence. |
Raw materials needed Active pharmaceutical ingredients and excipients essential for oral solid dosage manufacturing. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue primarily from recurring pharmaceutical product sales with steady demand patterns. |
Our industry position Recognized mid-sized pharma player with strong regional penetration and focus on quality and innovation. |
Financial highlights FY25 revenue around ₹50 crore with a net loss of ₹0.98 crore; Q3 FY26 EBITDA margin improved to over 10%. |
Geographical revenue split Majority revenue from domestic Indian markets across multiple states and districts. |
Order book - |
Whats driving growth Brand development, operational efficiency, focused portfolio rationalization, and expanding healthcare reach drive growth. |
Our future plans Enhancing brand equity, increasing market penetration, expanding product offerings, and maintaining financial discipline. |
Our green promise - |
Our people and values Over 240 employees with a strong focus on human capital development, ethical practices, and employee welfare. |
Key challenges ahead Managing competitive pressures, regulatory compliance, cost controls, and evolving healthcare demands. |
Interesting facts Maintains strict Good Manufacturing Practices and Good Laboratory Practices since inception for high safety and efficacy. |
Risks and strategy Mitigates risks via regulatory audits, vendor management, talent retention, and strategic investment approvals. |
